Publications:

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Mabs

Monnet, Céline C; Jorieux, Sylvie S; Souyris, Nathalie N; Zaki, Ouafa O; Jacquet, Alexandra A; Fournier, Nathalie N; Crozet, Fabien F; de Romeuf, Christophe C; Bouayadi, Khalil K; Urbain, Rémi R; Behrens, Christian K CK; Mondon, Philippe P; Fontayne, Alexandre A

Publication Date: 2014

Variant appearance in text: GC: V308P

PubMed Link: 24492301

Variant Present in the following documents:

• Main text

View BVdb publication page